Masimo

Masimo Net Income

Delisted

The Net Income of Masimo (MASI) as of Nov 22, 2026 is -151.50 M USD. In the previous year, Net Income was -304.90 M USD — a change of -50.31% (higher).

Net Income

-151.50 MUSD

YoY

-50.31%

Last updated:

In 2025, Masimo's profit amounted to -151.50 M USD, a -50.31% increase from the -304.90 M USD profit recorded in the previous year.

The Masimo Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2022
143.50 M USD
Jan 1, 2023
81.50 M USD
Jan 1, 2024
-304.90 M USD
Jan 1, 2025
-151.50 M USD
Jan 1, 2026 (e)
323.74 M USD
Jan 1, 2027 (e)
358.94 M USD
Jan 1, 2028 (e)
398.32 M USD
Jan 1, 2029 (e)
398.25 M USD
The Masimo Net Income history
YEARNet IncomeYoY
est398.25 MUSD-0.02%
est398.32 MUSD+10.97%
est358.94 MUSD+10.87%
est323.74 MUSD-313.69%
-151.50 MUSD-50.31%
-304.90 MUSD-474.11%
81.50 MUSD-43.21%
143.50 MUSD-37.50%
229.60 MUSD-4.45%
240.30 MUSD+22.47%
196.22 MUSD+1.38%
193.54 MUSD+47.05%
131.62 MUSD-56.23%
300.67 MUSD+260.94%
83.30 MUSD+14.87%
72.52 MUSD+24.22%
58.38 MUSD-6.25%
62.27 MUSD-2.24%
63.70 MUSD-13.37%
73.53 MUSD+38.14%
53.23 MUSD+66.72%
31.93 MUSD-24.44%
42.26 MUSD-76.76%
181.83 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Masimo Revenue

Masimo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
2.04 B USD
210.00 M USD
143.50 M USD
Jan 1, 2023
2.05 B USD
138.40 M USD
81.50 M USD
Jan 1, 2024
2.09 B USD
-261.70 M USD
-304.90 M USD
Jan 1, 2025
1.53 B USD
312.80 M USD
-151.50 M USD
Jan 1, 2026 (e)
1.63 B USD
498.99 M USD
323.74 M USD
Jan 1, 2027 (e)
1.75 B USD
557.22 M USD
358.94 M USD
Jan 1, 2028 (e)
1.89 B USD
617.50 M USD
398.32 M USD
Jan 1, 2029 (e)
1.97 B USD
617.25 M USD
398.25 M USD

Masimo Margins

Masimo stock margins

The Masimo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Masimo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Masimo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
52.01 %
10.32 %
7.05 %
Jan 1, 2023
49.00 %
6.76 %
3.98 %
Jan 1, 2024
47.96 %
-12.50 %
-14.56 %
Jan 1, 2025
61.90 %
20.49 %
-9.92 %
Jan 1, 2026 (e)
61.90 %
30.56 %
19.83 %
Jan 1, 2027 (e)
61.90 %
31.86 %
20.53 %
Jan 1, 2028 (e)
61.90 %
32.71 %
21.10 %
Jan 1, 2029 (e)
61.90 %
31.26 %
20.17 %

Masimo Stock analysis

What does Masimo do? Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Masimo's Profit Margins

The profit margins of Masimo represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Masimo's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Masimo's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Masimo's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Masimo’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Masimo stock

Net Income of Masimo is -151.50 M USD in 2025.

Net Income of Masimo changed from -304.90 M USD to -151.50 M USD, representing a -50.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Masimo since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Masimo historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Masimo

All Key Metrics — Masimo